Cheng Hongjiang, Yang Fengbing, Zhang Jing, Xu Lina, Jia Longbin, Zhao Doudou, Liu Wei, Li Huimin
Jincheng People's Hospital Affiliated to Shanxi Medical University, Jincheng, China.
Changzhi Medical College, Changzhi, China.
Front Neurol. 2021 Mar 17;12:648911. doi: 10.3389/fneur.2021.648911. eCollection 2021.
Anti--methyl-D-aspartate receptor (anti-NMDAR) encephalitis is an autoimmune disease associated with the NMDA receptor. This paper describes a patient who presented with bilateral hearing loss as the initial symptom of anti-NMDAR encephalitis. We describe a 31-year-old young female with anti-NMDAR encephalitis who presented with bilateral severe hearing loss after brief loss of consciousness and then accompanied by other symptoms, such as generalized tonic-clonic seizures, manic episodes, excessive salivation, severe cognitive impairment, and complex non-convulsive status epilepticus. Great improvement was achieved by a combined treatment of steroid, IVIG, and plasmapheresis, especially after surgical removal of the ovarian teratoma. When she was discharged on hospital day 43, her hearing loss obtained a significant improvement. This case study and literature review investigated the impairment of hearing loss and its subsequent treatment in patients with anti-NMDAR encephalitis.
抗 N-甲基-D-天冬氨酸受体(抗 NMDAR)脑炎是一种与 NMDAR 相关的自身免疫性疾病。本文描述了一名以双侧听力丧失为抗 NMDAR 脑炎初始症状的患者。我们报告了一名 31 岁患有抗 NMDAR 脑炎的年轻女性,她在短暂意识丧失后出现双侧严重听力丧失,随后伴有其他症状,如全身强直阵挛性发作、躁狂发作、流涎过多、严重认知障碍和复杂的非惊厥性癫痫持续状态。通过类固醇、静脉注射免疫球蛋白和血浆置换的联合治疗取得了显著改善,尤其是在手术切除卵巢畸胎瘤之后。当她在住院第 43 天出院时,听力损失有了明显改善。本病例研究和文献综述探讨了抗 NMDAR 脑炎患者听力损失的损害情况及其后续治疗。